Relationships between intestinal polyp formation and fatty acid levels in plasma, erythrocytes, and intestinal polyps in Min mice

Cancer Science

Volumn 99, Issue 12, 2008, Pages 2410-2416

  Kuriki, Kiyonori ^a   Mutoh, Michihiro ^b   Tajima, Kazuo ^a,c   Wakabayashi, Keiji ^b   Tatematsu, Masae ^a,c  

^a AICHI CANCER CENTER HOSPITAL   (Japan)

^b NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^c NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; DOCOSAHEXAENOIC ACID; FATTY ACID; ICOSAPENTAENOIC ACID; LINOLEIC ACID; LIPID; OLEIC ACID; PALMITIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; ERYTHROCYTE LEVEL; FATTY ACID BLOOD LEVEL; GAS LIQUID CHROMATOGRAPHY; HYPERLIPIDEMIA; INTESTINE MUCOSA; INTESTINE POLYP; LIPID BLOOD LEVEL; LIPID DIET; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; SOLVENT EXTRACTION; WILD TYPE;

ANIMALS; ARACHIDONIC ACID; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; ERYTHROCYTE MEMBRANE; ERYTHROCYTES; FATTY ACIDS; INTESTINAL POLYPS; LINOLEIC ACID; MALE; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; OLEIC ACIDS; PALMITIC ACID; PLASMA;

EID: 57349174462     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2008.00986.x     Document Type: Article

References (54)

1. World Cancer Research Fund/American Institute for Cancer Research. Food, Nutrition and the Prevention of Cancer: A Global Perspective. Washington DC: American Institute for Cancer Research, 1997.
2. Kono S, Ikeda N, Yanai F, Yamamoto M, Shigematsu T. Serum lipids and colorectal adenoma among male self-defence officials in northern Kyushu, Japan. Int J Epidemiol 1990; 19: 274-8.
3. McKeown-Eyssen G. Epidemiology of colorectal cancer revisited: Are serum triglycerides and/or plasma glucose associated with risk? Cancer Epidemiol Biomarkers Prev 1994; 3: 687-95.
4. Otani T, Iwasaki M, Ikeda S et al. Serum triglycerides and colorectal adenoma in a case-control study among cancer screening examinees (Japan). Cancer Causes Control 2006; 17: 1245-52.
5. Mutoh M, Akasu T, Takahashi M et al. Possible involvement of hyperlipidemia in increasing risk of colorectal tumor development in human familial adenomatous polyposis. Jpn J Clin Oncol 2006; 36: 166-71.
6. Niho N, Takahashi M, Kitamura T et al. Concomitant suppression of hyperlipidemia and intestinal polyp formation in Apc-deficient mice by peroxisome proliferator-activated receptor ligands. Cancer Res 2003; 63: 6090-5.
7. Niho N, Takahashi M, Shoji Y et al. Dose-dependent suppression of hyperlipidemia and intestinal polyp formation in Min mice by pioglitazone, a PPARγ ligand. Cancer Sci 2003; 94: 960-4.
8. Niho N, Mutoh M, Takahashi M, Tsutsumi K, Sugimura T, Wakabayashi K. Concurrent suppression of hyperlipidemia and intestinal polyp formation by NO-1886, increasing lipoprotein lipase activity in Min mice. Proc Natl Acad Sci USA 2005; 102: 2970-4.
9. Kuriki K, Wakai K, Hirose K et al. Risk of colorectal cancer is linked to erythrocyte compositions of fatty acids as biomarkers for dietary intakes of fish, fat and fatty acids. Cancer Epidemiol Biomarkers Prev 2006; 15: 1791-8.
10. Kuriki K, Tajima K, Tokudome S. Accelerated solvent extraction for quantitative measurement of fatty acids in plasma and erythrocytes. Lipids 2006; 41: 605-14.
11. Moser AR, Pitot HC, Dove WF. A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science 1990; 247: 322-4.
12. Mutoh M, Watanabe K, Kitamura T et al. Involvement of prostaglandin E receptor subtype EP (4) in colon carcinogenesis. Cancer Res 2002; 62: 28-32.
13. Kuriki K, Hirose K, Wakai K et al. Breast cancer risk and erythrocyte compositions of n-3 highly unsaturated fatty acids in Japanese. Int J Cancer 2007; 121: 377-85.
14. Hunter D. Biochemical indicators of dietary intake. In: Willett W, ed. Nutritional Epidemiology. New York: Oxford University Press, 1990; 186-16.
15. Nkondjock A, Shatenstein B, Maisonneuve P, Ghadirian P. Specific fatty acids and human colorectal cancer: An overview. Cancer Detect Prev 2003; 27: 55-66.
16. Nicholson ML, Neoptolemos JP, Clayton HA, Talbot IC, Bell PR. Dietary and erythrocyte fatty acids in experimental colorectal carcinogenesis. Eur J Surg Oncol 1992; 18: 146-51.
17. Nicholson ML, Neoptolemos JP, Clayton HA, Talbot IC, Bell PR. Increased cell membrane arachidonic acid in experimental colorectal tumours. Gut 1991; 32: 413-18.
18. Nicholson ML, Neoptolemos JP, Clayton HA, Talbot IC, Bell PR. Inhibition of experimental colorectal carcinogenesis by dietary N-6 polyunsaturated fats. Carcinogenesis 1990; 11: 2191-7.
19. Baro L, Hermoso JC, Nunez MC, Jimenez-Rios JA, Gil A. Abnormalities in plasma and red blood cell fatty acid profiles of patients with colorectal cancer. Br J Cancer 1998; 77: 1978-83.
20. Schloss I, Kidd MS, Tichelaar HY, Young GO, O'Keefe SJ. Dietary factors associated with a low risk of colon cancer in coloured west coast fishermen. S Afr Med J 1997; 87: 152-8.
21. Fernandez-Banares F, Esteve M, Navarro E et al. Changes of the mucosal n3 and n6 fatty acid status occur early in the colorectal adenoma-carcinoma sequence. Gut 1996; 38: 254-9.
22. Kojima M, Wakai K, Tokudome S et al. Serum levels of polyunsaturated fatty acids and risk of colorectal cancer: A prospective study. Am J Epidemiol 2005; 161: 462-71.
23. Huang YC, Jessup JM, Forse RA et al. n-3 fatty acids decrease colonic epithelial cell proliferation in high-risk bowel mucosa. Lipids 1996; 31 (Suppl): 313S-7S.
24. O'Keefe SJ, Kidd M, Espitalier-Noel G, Owira P. Rarity of colon cancer in Africans is associated with low animal product consumption, not fiber. Am J Gastroenterol 1999; 94: 1373-80.
25. Neoptolemos JP, Clayton H, Heagerty AM et al. Dietary fat in relation to fatty acid composition of red cells and adipose tissue in colorectal cancer. Br J Cancer 1988; 58: 575-9.
26. Hietanen E, Bartsch H, Bereziat JC et al. Diet and oxidative stress in breast, colon and prostate cancer patients: A case-control study. Eur J Clin Nutr 1994; 48: 575-86.
27. Kelly SB, Miller J, Wood CB, Williamson RC, Habib NA. Erythrocyte stearic acid desaturation in patients with colorectal carcinoma. Dis Colon Rectum 1990; 33: 1026-30.
28. Neoptolemos JP, Husband D, Imray C, Rowley S, Lawson N. Arachidonic acid and docosahexaenoic acid are increased in human colorectal cancer. Gut 1991; 32: 278-81.
29. Hendrickse CW, Kelly RW, Radley S, Donovan IA, Keighley MR, Neoptolemos JP. Lipid peroxidation and prostaglandins in colorectal cancer. Br J Surg 1994; 81: 1219-23.
30. Anti M, Marra G, Armelao F et al. Effect of omega-3 fatty acids on rectal mucosal cell proliferation in subjects at risk for colon cancer. Gastroenterology 1992; 103: 883-91.
31. Anti M, Armelao F, Marra G et al. Effects of different doses of fish oil on rectal cell proliferation in patients with sporadic colonic adenomas. Gastroenterology 1994; 107: 1709-18.
32. Bartram HP, Gostner A, Scheppach W et al. Effects of fish oil on rectal cell proliferation, mucosal fatty acids, and prostaglandin E2 release in healthy subjects. Gastroenterology 1993; 105: 1317-22.
33. Almendingen K, Hostmark AT, Fausa O, Mosdol A, Aabakken L, Vatn MH. Familial adenomatous polyposis patients have high levels of arachidonic acid and docosahexaenoic acid and low levels of linoleic acid and alpha-linolenic acid in serum phospholipids. Int J Cancer 2007; 120: 632-7.
34. Mutoh M, Niho N, Wakabayashi K. Concomitant suppression of hyperlipidemia and intestinal polyp formation by increasing lipoprotein lipase activity in Apc-deficient mice. Biol Chem 2006; 387: 381-5.
35. Lefebvre AM, Chen I, Desreumaux P et al. Activation of the peroxisome proliferator-activated receptor gamma promotes the development of colon tumors in C57BL/6J-APCMin/+ mice. Nat Med 1998; 4: 1053-7.
36. Saez E, Tontonoz P, Nelson MC et al. Activators of the nuclear receptor PPARγ enhance colon polyp formation. Nat Med 1998; 4: 1058-61.
37. Vamecq J, Latruffe N. Medical significance of peroxisome proliferator-activated receptors. Lancet 1999; 354: 141-8.
38. Vanden Heuvel JP. Peroxisome proliferator-activated receptors: A critical link among fatty acids, gene expression and carcinogenesis. J Nutr 1999; 129 (Suppl): 75S-80S.
39. Tanaka T, Kohno H, Yoshitani S et al. Ligands for peroxisome proliferator-activated receptors alpha and gamma inhibit chemically induced colitis and formation of aberrant crypt foci in rats. Cancer Res 2001; 61: 2424-8.
40. Kuriki K, Hirose K, Matsuo K et al. Meat, milk, saturated fatty acids, the Pro12Ala and C161T polymorphisms of the PPARγ gene and colorectal cancer risk in Japanese. Cancer Sci 2006; 97: 1226-35.
41. Kuhajda FP. Fatty acid synthase and cancer: New application of an old pathway. Cancer Res 2006; 66: 5977-80.
42. Accioly MT, Pacheco P, Maya-Monteiro CM et al. Lipid bodies are reservoirs of cyclooxygenase-2 and sites of prostaglandin-E2 synthesis in colon cancer cells. Cancer Res 2008; 68: 1732-40.
43. Yang VW, Shields JM, Hamilton SR et al. Size-dependent increase in prostanoid levels in adenomas of patients with familial adenomatous polyposis. Cancer Res 1998; 58: 1750-3.
44. Dong M, Guda K, Nambiar PR et al. Inverse association between phospholipase A2 and COX-2 expression during mouse colon tumorigenesis. Carcinogenesis 2003; 24: 307-15.
45. Boolbol SK, Dannenberg AJ, Chadburn A et al. Cyclooxygenase-2 overexpression and tumor formation are blocked by sulindac in a murine model of familial adenomatous polyposis. Cancer Res 1996; 56: 2556-60.
46. DuBois RN, Radhika A, Reddy BS, Entingh AJ. Increased cyclooxygenase-2 levels in carcinogen-induced rat colonic tumors. Gastroenterology 1996; 110: 1259-62.
47. Williams CS, Luongo C, Radhika A et al. Elevated cyclooxygenase-2 levels in Min mouse adenomas. Gastroenterology 1996; 111: 1134-40.
48. Rigas B, Goldman IS, Levine L. Altered eicosanoid levels in human colon cancer. J Lab Clin Med 1993; 122: 518-23.
49. Pugh S, Thomas GA. Patients with adenomatous polyps and carcinomas have increased colonic mucosal prostaglandin E2. Gut 1994; 35: 675-8.
50. Eberhart CE, Coffey RJ, Radhika A, Giardiello FM, Ferrenbach S, DuBois RN. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 1994; 107: 1183-8.
51. Sano H, Kawahito Y, Wilder RL et al. Expression of cyclooxygenase-1 and -2 in human colorectal cancer. Cancer Res 1995; 55: 3785-9.
52. Giardiello FM, Spannhake EW, DuBois RN et al. Prostaglandin levels in human colorectal mucosa: Effects of sulindac in patients with familial adenomatous polyposis. Dig Dis Sci 1998; 43: 311-16.
53. Khan KN, Masferrer JL, Woerner BM, Soslow R, Koki AT. Enhanced cyclooxygenase-2 expression in sporadic and familial adenomatous polyposis of the human colon. Scand J Gastroenterol 2001; 36: 865-9.
54. Mutoh M, Takahashi M, Wakabayashi K. Roles of prostanoids in colon carcinogenesis and their potential targeting for cancer chemoprevention. Curr Pharm Des 2006; 12: 2375-82.